DPDouglas R. Pfeiffer

Douglas R. Pfeiffer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Douglas R. Pfeiffer has a total of 26 co-authors. Here are the top co-authors by number of shared publications:

  • Kimberly M. Broekemeier

    §Department of Chemistry and Biochemistry, Ohio Northern University, Ada, OH 45810

    3 shared publications
  • Elliott D. Crouser

    2 shared publications
  • Gustav Graff

    The Ophthalmic Products Research Group, Alcon Research Ltd., Fort Worth, TX 76134, USA

    2 shared publications
  • Jitendra Kumar

    The Department of Molecular and Cellular Biochemistry, The Institute for Mitochondrial Biology, The Ohio State University, Columbus, OH 43210, USA

    2 shared publications
  • Martha E. Gadd

    Department of Molecular and Cellular Biochemistry, Ohio State University, 1645 Neil Avenue, Columbus, OH 43210, USA

    2 shared publications
  • Adam J. Rauckhorst

    Abboud Cardiovascular Research Center, University of Iowa Carver College of Medicine, Iowa City, USA

    1 shared publication

Latest Publications

  • Open Access

    Regulation of the Ca -independent phospholipase A2 in liver mitochondria by changes in the energetic state

    by Adam J. Rauckhorst, Kimberly M. Broekemeier, Douglas R. Pfeiffer


  • Preservation of the NADPH redox system is not responsible for the protective effects of ischemic preconditioning

    by Ricardo Quarrie, Daniel S. Lee, Brandon Cramer, Warren Erdahl, Douglas R. Pfeiffer, Jay L. Zweier, Juan A. Crestanello

  • Differential effects of non-steroidal anti-inflammatory drugs on mitochondrial dysfunction during oxidative stress

    by Nirupama Lal, Jitendra Kumar, Warren E. Erdahl, Douglas R. Pfeiffer, Martha. E. Gadd, Gustav Graff, John M. Yanni


  • Open Access

    Monensin Improves the Effectiveness of meso -Dimercaptosuccinate when Used to Treat Lead Intoxication in Rats

    by Shawn A. Hamidinia, Warren L. Erdahl, Clifford J. Chapman, Gregory E. Steinbaugh, Richard W. Taylor, Douglas R. Pfeiffer

    Among divalent cations, the ionophore monensin shows high activity and selectivity for the transport of lead ions (Pb2+) across phospholipid membranes. When coadministered to rats that were receiving meso-dimercaptosuccinate for treatment of Pb intoxication, monensin significantly increased the amount of Pb removed from femur, brain, and heart. It showed a tendency to increase Pb removal from liver and kidney but had no effect of this type in skeletal muscle. Tissue levels of several physiologic (calcium, cobalt, copper, iron, magnesium, manganese, molybdenum, zinc) and nonphysiologic (arsenic, cadmium, chromium, nickel, strontium) elements were also determined after the application of these compounds. Among the physiologic elements, a number of significant changes were seen, including both rising and falling values. The size of these changes was typically around 20% compared with control values, with the largest examples seen in femur. These changes often tended to reverse those of similar size that had occurred during Pb administration. Among the nonphysiologic elements, which were present in trace amounts, the changes were smaller in number but larger in size. None of these changes appears likely to be significant in terms of toxicity, and there were no signs of overt toxicity under any of the conditions employed. Monensin may act by cotransporting Pb2+ and OH– ions out of cells, in exchange for external sodium ions. The net effect would be to shuttle intracellular Pb2+ to extracellular dimercaptosuccinic acid thereby enhancing its effectiveness. Thus, monensin may be useful for the treatment of Pb intoxication when applied in combination with hydrophilic Pb2+ chelators.


  • Open Access

    Mitochondrial iPLA2 Activity Modulates the Release of Cytochrome c from Mitochondria and Influences the Permeability Transition

    by Martha E. Gadd, Kimberly M. Broekemeier, Elliott D. Crouser, Jitendra Kumar, Gustav Graff, Douglas R. Pfeiffer


  • Open Access

    Release of Ca2+ and Mg2+ from yeast mitochondria is stimulated by increased ionic strength

    by Patrick C Bradshaw, Douglas R Pfeiffer

    Background: Divalent cations are required for many essential functions of mitochondrial metabolism. Yet the transporters that mediate the flux of these molecules into and out of the mitochondrion remain largely unknown. Previous studies in yeast have led to the molecular identification of a component of the major mitochondrial electrophoretic Mg2+uptake system in this organism as well as a functional mammalian homolog. Other yeast mitochondrial studies have led to the characterization of an equilibrative fatty acid-stimulated Ca2+transport activity. To gain a deeper understanding of the regulation of mitochondrial divalent cation levels we further characterized the efflux of Ca2+and Mg2+from yeast mitochondria.Results: When isolated mitochondria from the yeastSaccharomyces cerevisiaewere suspended in a salt-based suspension medium, Ca2+and Mg2+were released from the matrix space. Release did not spontaneously occur in a non-ionic mannitol media. When energized mitochondria were suspended in a mannitol medium in the presence of Ca2+they were able to accumulate Ca2+by the addition of the electrogenic Ca2+ionophore ETH-129. However, in a KCl or choline Cl medium under the same conditions, they were unable to retain the Ca2+that was taken up due to the activation of the Ca2+efflux pathway, although a substantial membrane potential driving Ca2+uptake was maintained. This Ca2+efflux was independent of fatty acids, which have previously been shown to activate Ca2+transport. Endogenous mitochondrial Mg2+was also released when mitochondria were suspended in an ionic medium, but was retained in mitochondria upon fatty acid addition. When suspended in a mannitol medium, metal chelators released mitochondrial Mg2+, supporting the existence of an external divalent cation-binding site regulating release. Matrix space Mg2+was also slowly released from mitochondria by the addition of Ca2+, respiratory substrates, increasing pH, or the nucleotides ATP, ADP, GTP, and ATP-gamma-S.Conclusion: In isolated yeast mitochondria Ca2+and Mg2+release was activated by increased ionic strength. Free nucleotides, metal ion chelators, and increased pH also stimulated release. In yeast cells this release is likely an important mechanism in the regulation of mitochondrial matrix space divalent cation concentrations.


  • Open Access

    Loss of NAD(H) from swollen yeast mitochondria

    by Patrick C Bradshaw, Douglas R Pfeiffer

    The mitochondrial electron transport chain oxidizes matrix space NADH as part of the process of oxidative phosphorylation. Mitochondria contain shuttles for the transport of cytoplasmic NADH reducing equivalents into the mitochondrial matrix. Therefore for a long time it was believed that NAD(H) itself was not transported into mitochondria. However evidence has been obtained for the transport of NAD(H) into and out of plant and mammalian mitochondria. Since Saccharomyces cerevisiae mitochondria can directly oxidize cytoplasmic NADH, it remained questionable if mitochondrial NAD(H) transport occurs in this organism. NAD(H) was lost more extensively from the matrix space of swollen than normal, condensed isolated yeast mitochondria from Saccharomyces cerevisiae. The loss of NAD(H) in swollen organelles caused a greatly decreased respiratory rate when ethanol or other matrix space NAD-linked substrates were oxidized. Adding NAD back to the medium, even in the presence of a membrane-impermeant NADH dehydrogenase inhibitor, restored the respiratory rate of swollen mitochondria oxidizing ethanol, suggesting that NAD is transported into the matrix space. NAD addition did not restore the decreased respiratory rate of swollen mitochondria oxidizing the combination of malate, glutamate, and pyruvate. Therefore the loss of matrix space metabolites is not entirely specific for NAD(H). However, during NAD(H) loss the mitochondrial levels of most other nucleotides were maintained. Either hypotonic swelling or colloid-osmotic swelling due to opening of the yeast mitochondrial unspecific channel (YMUC) in a mannitol medium resulted in decreased NAD-linked respiration. However, the loss of NAD(H) from the matrix space was not mediated by the YMUC, because YMUC inhibitors did not prevent decreased NAD-linked respiration during swelling and YMUC opening without swelling did not cause decreased NAD-linked respiration. Loss of endogenous NAD(H) from isolated yeast mitochondria is greatly stimulated by matrix space expansion. NAD(H) loss greatly limits NAD-linked respiration in swollen mitochondria without decreasing the NAD-linked respiratory rate in normal, condensed organelles. NAD addition can totally restore the decreased respiration in swollen mitochondria. In live yeast cells mitochondrial swelling has been observed prior to mitochondrial degradation and cell death. Therefore mitochondrial swelling may stimulate NAD(H) transport to regulate metabolism during these conditions.


  • Quantitation of cytochrome c release from rat liver mitochondria

    by Elliott D. Crouser, Martha E. Gadd, Mark W. Julian, Jennifer E. Huff, Kimberly M. Broekemeier, Karen A. Robbins, Douglas R. Pfeiffer